Search results
3 Things You Need to Know If You Buy Novavax Today
The Motley Fool via AOL· 3 days agoThat's why Sanofi's agreement to co-commercialize Novavax's vaccine as of next year is such positive news for the smaller company. In addition, Sanofi...
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 6 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 1 day agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 5 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 3 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 4 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 3 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 3 days agoNovavax and Inovio have soared since 2024 started. Which of these two biotechs can outperform the other moving forward? Let's take a look. NVAX data by...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoNovavax. It is entitled to up to $700 million related to various clinical and regulatory milestones...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...